GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $22,014,000 | +15.5% | 505,711 | +15.5% | 0.02% | +31.2% |
Q1 2022 | $19,064,000 | -0.3% | 437,657 | +1.0% | 0.02% | 0.0% |
Q4 2021 | $19,115,000 | +28.7% | 433,449 | +11.6% | 0.02% | +14.3% |
Q3 2021 | $14,847,000 | -4.4% | 388,553 | -0.4% | 0.01% | -12.5% |
Q2 2021 | $15,537,000 | +15.6% | 390,177 | +3.6% | 0.02% | +6.7% |
Q1 2021 | $13,435,000 | +15.8% | 376,440 | +19.4% | 0.02% | 0.0% |
Q4 2020 | $11,606,000 | -45.0% | 315,392 | -43.8% | 0.02% | -54.5% |
Q3 2020 | $21,106,000 | -19.6% | 560,722 | -12.8% | 0.03% | -28.3% |
Q2 2020 | $26,241,000 | +5.2% | 643,316 | -2.3% | 0.05% | -14.8% |
Q1 2020 | $24,937,000 | -23.0% | 658,142 | -4.5% | 0.05% | -8.5% |
Q4 2019 | $32,388,000 | +19.2% | 689,255 | +8.3% | 0.06% | +7.3% |
Q3 2019 | $27,175,000 | +7.5% | 636,713 | +0.8% | 0.06% | +1.9% |
Q2 2019 | $25,269,000 | -0.3% | 631,420 | +4.1% | 0.05% | -6.9% |
Q1 2019 | $25,341,000 | +18.8% | 606,386 | +8.6% | 0.06% | +1.8% |
Q4 2018 | $21,332,000 | -1.9% | 558,291 | +3.1% | 0.06% | +9.6% |
Q3 2018 | $21,743,000 | -3.1% | 541,285 | -2.8% | 0.05% | -11.9% |
Q2 2018 | $22,447,000 | +2.3% | 556,870 | -0.9% | 0.06% | -1.7% |
Q1 2018 | $21,949,000 | +185.6% | 561,798 | +159.3% | 0.06% | +160.9% |
Q4 2017 | $7,686,000 | -37.2% | 216,692 | -28.1% | 0.02% | -46.5% |
Q3 2017 | $12,241,000 | -15.4% | 301,514 | -10.1% | 0.04% | -21.8% |
Q2 2017 | $14,469,000 | +7.6% | 335,550 | +4.9% | 0.06% | -40.2% |
Q1 2017 | $13,453,000 | +10.1% | 320,014 | +1.7% | 0.09% | -1.1% |
Q4 2016 | $12,215,000 | -9.5% | 314,650 | +1.2% | 0.09% | -27.3% |
Q3 2016 | $13,503,000 | +1.3% | 311,034 | +1.7% | 0.13% | +13.3% |
Q2 2016 | $13,334,000 | -39.5% | 305,694 | -44.0% | 0.11% | +85.2% |
Q1 2016 | $22,029,000 | +11.2% | 545,676 | +12.0% | 0.06% | +10.9% |
Q4 2015 | $19,806,000 | +82.4% | 487,088 | +78.6% | 0.06% | -8.3% |
Q3 2015 | $10,857,000 | -7.6% | 272,794 | -2.6% | 0.06% | 0.0% |
Q2 2015 | $11,744,000 | -19.5% | 280,133 | -10.4% | 0.06% | -20.0% |
Q1 2015 | $14,591,000 | +26.6% | 312,499 | +15.9% | 0.08% | +19.0% |
Q4 2014 | $11,527,000 | +12.6% | 269,707 | +21.0% | 0.06% | +3.3% |
Q3 2014 | $10,233,000 | +24.7% | 222,942 | +45.3% | 0.06% | +27.1% |
Q2 2014 | $8,208,000 | +11.1% | 153,478 | +11.0% | 0.05% | +6.7% |
Q1 2014 | $7,387,000 | -2.5% | 138,262 | -2.6% | 0.04% | -4.3% |
Q4 2013 | $7,576,000 | +9.2% | 141,902 | +2.9% | 0.05% | +2.2% |
Q3 2013 | $6,940,000 | -6.5% | 137,841 | -7.2% | 0.05% | -13.2% |
Q2 2013 | $7,420,000 | – | 148,479 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |